Each year, millions of dollars are spent on U.S. healthcare and now a Maryland study indicates the expenditure is worth it -- and has a positive return.
Bryan Luce, senior research scientist for the United BioSource Corp., said the study he led especially applies to those who suffer a heart attack, stroke, type two diabetes or breast cancer.
"We calculate that over the last 20 years, the return on investment is positive for overall national healthcare spending; Medicare spending on heart attack, stroke, breast cancer and diabetes; and all major healthcare innovations which we could both identify and which were associated with (the) four diseases," said Luce.
Specifically, he says each additional dollar spent on overall healthcare services was calculated to produce health gains valued from $1.55 to as much as $1.94.
Luce said the study demonstrates it is possible to validly estimate the value of healthcare spending. The authors conclude cost should not be considered in isolation without estimating the value of the investment in healthcare.
The research appears in the publication Value in Health.
Copyright 2006 by United Press International
Related stories:
Adherence to antiretroviral therapy high in children in low income countries
Researchers from the Indiana University School of Medicine, the Regenstrief Institute and Moi University School of Medicine are the first to report that adherence to antiretroviral therapy (ART) to fight human immunodeficiency virus (HIV) in children who live in low income countries is as high as or higher than adherence by children living in high income countries.
Lack of time on tummy shown to hinder achievement
The American Physical Therapy Association (APTA) is urging parents and caregivers to ensure that babies get enough "tummy time" throughout the day while they are awake and supervised, in light of a recent survey of therapists who say they've noticed an increase in motor delays in infants who spend too much time on their backs while awake.
Study suggests 86 percent of Americans could be overweight or obese by 2030
Most adults in the U.S. will be overweight or obese by 2030, with related health care spending projected to be as much as $956.9 billion, according to researchers at the Johns Hopkins Bloomberg School of Public Health, the Agency for Healthcare Research and Quality and the University of Pennsylvania School of Medicine. Their results are published in the July 2008 online issue of
Obesity.
Overweight elderly Americans contribute to financial burdens of the US health care system
Being overweight or obese is not only a personal issue that affects one's health but is also a public health issue that impacts other people in society. A new study in the journal
Health Services Research reveals that the extra Medicare cost associated with overweight elderly people could place a significant financial burden on tax payers, costing up to hundreds of billions of dollars across the entire current Medicare population.
New research links International Monetary Fund loans with higher death rates from tuberculosis
International Monetary Fund (IMF) loans were associated with a 16.6% rise in death rates from tuberculosis (TB) in the former Soviet Union and Central and Eastern European countries between 1992 and 2002, finds a study in this week's
PLoS Medicine.
Humor plays an important role in healthcare even when patients are terminally ill
Humour can play an essential role in the most serious healthcare settings, even when patients are receiving intensive or end of life care, according to research in the April issue of the UK-based
Journal of Clinical Nursing.
Virtual reality and computer technology improve stroke rehabilitation
Israeli hospitals have recently started to use virtual reality therapy for stroke patients. One commonly used program has the patient watch his virtual image on a screen. For example, tennis balls are virtually thrown at the patient from all directions and the patients' actual hand motions are recorded on screen.
Bacteria beware: MIT graduate invents knock-out punch for antibiotic resistance
MIT graduate student and synthetic biologist Timothy Lu is passionate about tackling problems that pose threats to human health. His current mission: to destroy antibiotic-resistant bacteria.